Biologicals in rheumatoid arthritis: current and future - RMD Open
WEBThe aim of the review is to highlight the current knowledge about established and new biologicals and to summarise recent advances by focusing on comparative efficacy, safety and possible discontinuation of treatment in patients with rheumatoid arthritis (RA). Up to now, comparative analyses showed only minor differences with respect to efficacy and safety among the established biologicals.
Risk of developing psoriatic arthritis in psoriasis cohorts with ...
WEBObjective Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) estimate the probability of PsA development in subclinical PsA, (2) characterise subclinical PsA symptoms and (3) determine the clinical patterns at PsA diagnosis. Methods Patients with PsO ...
Homepage | RMD Open | A leading rheumatology journal from …
WEBRMD Open. RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies ...
WEBORIGINAL ARTICLE DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable Roy M Fleischmann,1 Désirée van der Heijde,2 Philip V Gardiner,3 Annette Szumski,4 Lisa Marshall,5 Eustratios Bananis5 To cite: Fleischmann RM,
WEBMixed connective tissue disease (MCTD) was initially described by Sharp et al.1 MCTD was first reported as a mild overlap disease with features of different autoimmune connec-tive tissue diseases (CTDs) namely systemic sclerosis, poly/dermatomyositis and systemic lupus erythematous in patients with anti-bodies targeting the U1 small nuclear ...
Diagnostic issues in difficult-to-treat rheumatoid arthritis: a ...
WEBObjectives To summarise the evidence on diagnostic issues in difficult-to-treat rheumatoid arthritis (D2T RA) informing the EULAR recommendations for the management of D2T RA. Methods A systematic literature review (SLR) was performed regarding the optimal confirmation of a diagnosis of rheumatoid arthritis (RA) and of mimicking diseases and the assessment of inflammatory disease activity ...
WEBIdiopathic inflammatory myopathies (IIMs) encompass a heterogeneous group of rare autoimmune diseases characterised by muscle weakness and inflammation, but in antisynthetase syndrome arthritis and interstitial lung disease are more frequent and often inaugurate the disease. Clinical practice guidelines …
WEBromo C et al. RMD Open 2184:e78 doi:11136rmdopen21878 1 Review Sjögren’s syndrome: state of the art on clinical practice guidelines Vasco C Romão,1 Rosaria Talarico,2 Carlo Alberto Scirè,3 Ana Vieira,4 Tobias Alexander,5 Chiara Baldini,2,6 Jacques-Eric Gottenberg,7 Heidi Gruner,8 Eric Hachulla,9 Luc Mouthon,10 Martina Orlandi,11 Cristina Pamfil,12 Marc Pineton de Chambrun,13 Marco ...
WEBAntunes M et al. RMD Open 214:e doi:1113rmdopen21 1 REVIEW Undifferentiated connective tissue disease: state of the art on clinical practice guidelines Margarida Antunes,1 Carlo Alberto Scirè, 2 Rosaria Talarico,3 Tobias Alexander, 4 Tadej Avcin,5 Chiara Belocchi,6 Andrea Doria,7 Franco Franceschini,8 Ilaria Galetti,9 Marcello Govoni,10 Eric Hachulla,11 David Launay,11 Gemma Lepri,12
Management of lupus nephritis: a systematic literature ... - RMD …
WEBObjectives To analyse the current evidence for the management of lupus nephritis (LN) informing the 2019 update of the EULAR/European Renal Association-European Dialysis and Transplant Association recommendations. Methods According to the EULAR standardised operating procedures, a PubMed systematic literature review was performed, from January 1, 2012 to December 31, 2018. Since this was an ...